Ensysce Biosciences Inc (ENSC) — Cash Flow Reinvestment Rate
Ensysce Biosciences Inc (ENSC) has a Cash Flow Reinvestment Rate of 0.99x as of March 2020, reinvesting $134.62 Million (capex $4.00 plus investments $134.62 Million) from operating cash flow of $136.09 Million. See free cash flow generation of Ensysce Biosciences Inc to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Ensysce Biosciences Inc Cash Flow Reinvestment Rate (2019–2019)
Historical reinvestment intensity for Ensysce Biosciences Inc across 1 annual periods. For the full cash flow conversion analysis, see ENSC cash flow metrics.
Annual Cash Flow Reinvestment Rate for Ensysce Biosciences Inc (2019–2019)
Year-by-year capital reinvestment analysis for Ensysce Biosciences Inc. See Ensysce Biosciences Inc (ENSC) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 1.08x | $11.85 Million | $10.99 Million | $4.00 | — |